Clozapine plus lamotrigine in treatment-resistant schizophrenia [1]

Archives of General Psychiatry

Volumn 56, Issue 10, 1999, Pages 950-

  Dursun, Serdar M ^a   McIntosh, Diane ^b   Milliken, Heather ^b  

^a DALHOUSIE UNIVERSITY   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; LAMOTRIGINE;

DRUG EFFECT; DRUG EFFICACY; LETTER; NEUROTRANSMITTER RELEASE; RATING SCALE; SCHIZOPHRENIA;

ADULT; AMBULATORY CARE; ANTICONVULSANTS; ANTIPSYCHOTIC AGENTS; CLOZAPINE; FEMALE; HUMANS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; TREATMENT OUTCOME; TRIAZINES;

EID: 0344979751     PISSN: 0003990X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpsyc.56.10.950     Document Type: Letter

References (3)

1. Conley RR, Buchanan RW. Evaluation of treatment-resistant schizophrenia. Schizophr Bull. 1997;23:663-674.
2. Messenheimer J. Lamotrigine. Epilepsia. 1995;36(suppl 2):S87-S94.
3. Deakin JF, Slater P, Simpson MD, Gilchrist AC, Skan WJ, Royston MC, Reynolds GP, Cross AJ. Frontal cortical and left temporal glutamatergic dysfunction in schizophrenia. J Neurochem. 1989;52:1781-1786.